Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study ...

Verona Pharma's Ohtuvayre launch drives rapid growth and global expansion. Read about the VRNA stock's Q1 results, analyst insights, and future rally potential.

Elgan Pharma and Chiesi Group Announce First Participating Infants Dosed in Phase 3 Study of ELGN-2112 for Treatment of Intestinal Malabsorption in Preterm Infants Elgan Pharma and Chiesi Group ...

Jazz Pharma's Zepzelca plus Tecentriq significantly improved survival in a Phase 3 study for extensive-stage small-cell lung cancer patients.

Objectives To assess the upstream pharmaceutical supply chains of 10 high-use pharmaceuticals to detect vulnerabilities that may increase the risk of medicine shortages. Design Cohort study. Setting ...

With numerous companies investing in novel primary immune deficiency therapies, the pharmaceutical product launch of emerging treatments is expected to reshape the competitive landscape significantly.

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes drug in the next four to five years, Managing Director Dilip Shanghvi ...

In the dynamic pharmaceutical industry, successful product launches are critical to business success. For small and midsized biotech firms, where the reliance on a few key assets is high, the stakes ...

Silo Pharma, Inc. announced encouraging preliminary results from an ongoing study of its SP-26 ketamine extended-release rods, which are being evaluated for safety and pharmacokinetics after being ...

Traws Pharma (TRAW) announced completion of Phase I clinical studies of its investigational one-dose influenza therapy, tivoxavir marboxil, for the treatment or prevention of H5N1 bird flu.

The study, launched in the UK on Jan. 10, is built on the Pharma Proteomics Project, a pilot program set up in 2020.

“I was delighted with the launch of the Intelligent Messaging solution. It vindicated our belief that our customers would choose us for their managed email solution because they knew and trusted our ...